NEW YORK (GenomeWeb News) — Ariadne yesterday said that Bayer HealthCare has renewed and expanded a licensing agreement that allows it to use the company’s Pathway Studio through 2010 for toxicology studies and microarray data analysis.
 
The Ariadne data-mining software is used to analyze pathways, signaling networks, and to interpret microarray data, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.